[1] Barnes PJ.Cellular and molecular mechanisms of chronic obstructive pulmonary disease[J].Clin Chest Med,2014,35(1):71-86.[2] Haigis MC,Sinclair DA.Mammalian sirtuins:biological insights and disease relevance[J].Annu Rev Pathol,2010,5(3):253-295.[3] Rajendrasozhan S,Yang SR,Kinnula VL,et al.SIRT1,an antiinflammatory and antiaging protein,is decreased in lungs of patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2008,177(8):861-870.[4] Hwang JW,Chung S,Sundar IK,et al.Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism:implication in pathogenesis of COPD[J].Arch Biochem Biophys,2010,500(2):203-209.[5] Lim JH,Lee YM,Chun YS,et al.Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha[J].Mol Cell,2010,38(6):864-878.[6] Dioum EM,Chen R,Alexander MS,et al.Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1[J].Science,2009,324(5932):1289-1293.[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17.[8] 张振芳,王在义.COPD基因研究进展[J].临床肺科杂志,2014,19(1):124-127.[9] Moynihan KA,Grimm AA,Plueger MM,et al.Increased dosage of mammalian Sir2 in panereatic beta cells enhances glucose-stimulated insulin secretion in mice[J].Cell Metab,2005,2(2):105-117.[10] Ota H,Eto M,Ogawa S,et al.Sirt1/eNOS axis as a potential target against vascular senescence,dysfunction and atherosclerosis[J].J Atheroscler Thromb,2010,17 (5):431-435.[11] Li X,Zhang S,Blander G,et al.SIRT1 deacetylates and positively regulates the nuclear receptor LXR[J].Mol Cell,2007,28(1):91-106.[12] Nakamaru Y,Vuppusetty C,Wada H,et al.A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9[J].FASEB J,2009,23(9):2810-2819.[13] Fong GH.Mechanisms of adaptive angiogenesis to tissue hypoxia[J].Angiogenesis,2008,11(2):121-140.[14] Adams JM,Difazio LT,Rolandelli RH,et al.HIF-1:a key mediator in hypoxia[J].Acta Physiol Hung,2009,96 (1):19-28.[15] Schumacker PT.Hypoxia-inducible factor-1 (HIF-1) [J].Crit Care Med,2005,33(12 Suppl):S423-S425.[16] 魏文婷,李冰,贾晔然,等.慢性阻塞性肺疾病患者肺组织中缺氧诱导因子1α的表达变化[J].中国病理生理杂志,2013,29(9):1700-1703.[17] 徐永芳,孙维罗,孙燕.ET-1、VEGF、HIF-1α在COPD合并肺动脉高压形成中的意义[J].心脑血管病防治,2010,10(5):339-340.[18] Mizuno S,Bogaard HJ,Gomez-Arroyo J,et al.MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD[J].Chest,2012,142(3):663-672.[19] Putra AC,Tanimoto K,Arifin M,et al.Genetic variations in detoxification enzymes and HIF-1α in Japanese patients with COPD[J].Clin Respir J,2013,7(1):7-15.[20] 王宗强,于荣秀,吴健红,等.缺氧诱导因子-1 在COPD患者外周血单个核细胞中的表达[J].广东医学,2011,32(1):64-66. |